One of the largest medical device makers in Massachusetts has recalled a remote control for one of its insulin pumps, and the U.S. Food and Drug Administration this week gave the recall its most urgent classification.
Insulet Corp. (Nasdaq: PODD) issued a voluntary recall last month for its Omnipod DASH Insulin Management System’s Personal Diabetes Manager. The device involves two components: a wearable pump that injects insulin into the body; and a battery-powered, smartphone-like remote control…
